P137 Response to erythropoietin (EPO) with or without differentiating treatment with 13-cis-retinoic-acid and dihydroxylated vitamin D3 in myelodysplastic syndromes (MDS)Dario Ferrero, Alessandro Levis, Daniela Gioia et al.|Leukemia Research|2007Cited by 0
P002 Clinical and epidemiological considerations on myelodysplastic syndromes (MDS). The experience of the Piedmont MDS RegisterDaniela Gioia, A. Levis, Carola Boccomini et al.|Leukemia Research|2007Cited by 0